|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 15/117 | (2010.01) |
| A61K 31/70 | (2006.01) | ||
| A61K 8/00 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 2405002 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11183857.9 |
| Date of filing the European patent application | 2007-02-15 | |
| (97) | Date of publication of the European application | 2012-01-11 |
| (45) | Date of publication and mention of the grant of the patent | 2014-09-24 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 773505 P | 2006-02-15 | US | |
| 858240 P | 2006-11-09 | US |
| (72) |
Uhlmann, Eugen, DE
Vollmer, Joerg, DE
Krieg, Arthur M., US
Samulowitz, Ulrike, DE
Noll, Bernhard, DE
|
| (73) |
AdiuTide Pharmaceuticals GmbH,
Alt Fechenheim 34, 60386 Frankfurt am Main,
DE
|
| (54) | Compositions and methods for oligonucleotide formulations |
| Compositions and methods for oligonucleotide formulations |